Jiangsu Hengrui Pharmaceuticals company profile
Company profile
Jiangsu Hengrui Pharmaceuticals has 20,602 employees and is headquartered in Lianyungang, China.
Patients and healthcare providers in China and abroad are the people Jiangsu Hengrui Pharmaceuticals serves with medicines it researches, develops, manufactures and commercializes to address clinical needs that remain unmet. Its medicines cover oncology, metabolic and cardiovascular diseases, immunological and respiratory conditions, neuroscience, pain management, infectious diseases, hematological disorders, ophthalmology and autoimmune illnesses, among other areas.
In the fiscal year ended December 2025, revenue reached 31.6 billion yuan, up 13% from the previous year, while net profit amounted to 7.7 billion yuan. The group employs 20,602 people and is headquartered in Lianyungang, China, where it was set up in 1970.
Company facts
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- China
- Headquarters
- No. 38, Huanghe Road, 222047, Lianyungang
- Employees
- 20,602
- Chief executive
- Ji Feng
- Founded
- 1970
- Fiscal year
- January - December
- Listing
- 600276 · SSE
- Currency
- CNY
- ISIN
- CNE0000014W7
- Website
- hengrui.com
Jiangsu Hengrui Pharmaceuticals and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| Jiangsu Hengrui Pharmaceuticals600276 | China | $46.71B | 20,602 | 27.4% | 35.1 |
| Sun Pharmaceutical IndustriesSUNPHARMA | India | $48.8B | 47,000 | 23.3% | 41.2 |
| Divi's LaboratoriesDIVISLAB | India | $32.03B | 11,565 | 34.0% | 88.2 |
| Takeda Pharmaceutical4502 | Japan | $70.21B | 47,029 | 16.6% | 312.4 |
| Hansoh Pharmaceutical Group3692 | Hong Kong SAR China | $23.77B | 9,643 | 37.3% | 25.0 |
| Torrent PharmaceuticalsTORNTPHARM | India | $19.25B | 18,258 | 22.2% | 79.2 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
Compare Jiangsu Hengrui Pharmaceuticals with its competitors
